Company Search:
Advanced Search
Sponsored Links
Solasia Pharma KK Company Snapshot
Solasia Pharma KK operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Solasia Pharma KK with three other pharmaceutical manufacturers in Asia: Helixmith Co Ltd of South Korea (2018 sales of 5.28 billion Korean Won [US$4.53 million] of which 60% was Drug Medicine Research and Development), Innovent Biologics Inc of Hong Kong (11.22 million Hong Kong Dollars [US$1.44 million] of which 100% was Biopharmaceutical), and Peptron Inc which is based in South Korea (3.86 billion Korean Won [US$3.31 million] of which 48% was Finished Goods).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Solasia Pharma KK
  Stock Performance Chart for Solasia Pharma KK
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 177.00
(Figures in Japanese Yen)
1 Week -4.8%   13 Weeks -6.3%  
4 Weeks 15.7%   52 Weeks 7.9%  
Solasia Pharma KK Key Data:
  Ticker: 4597 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 318,000,000
(Year Ending Jan 2019).
Employees: 31
  Currency: Japanese Yen Market Cap: 18,608,150,715
  Fiscal Yr Ends: December Shares Outstanding: 105,130,795
  Share Type: COMMON Closely Held Shares: 30,428,822
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.